A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Participants With Epidermal Growth Factor Receptor (EGFR)-Mutated Advanced or Metastatic Non-small Cell Lung Cancer (PALOMA-3)
Project details
Funding institution
Diğer (Uluslararası)
Duration
20.03.2023
Unit
Faculty of Medicine • Department of Internal Medicine
